Abstract
Purpose
Postoperative ileus (POI) is an iatrogenic complication of abdominal surgery, mediated by a severe inflammation of the muscularis externa (ME). Previously, we demonstrated that intravenous application of the tetravalent guanylhydrazone semapimod (CNI-1493) prevents POI, but the underlying mode of action could not definitively be confirmed. Herein, we investigated the effect of a novel orally active salt of semapimod (CPSI-2364) on POI in rodents and distinguished between its inhibitory peripheral and stimulatory central nervous effects on anti-inflammatory vagus nerve signaling.
Methods
Distribution of radiolabeled orally administered CPSI-2364 was analyzed by whole body autoradiography and liquid scintillation counting. POI was induced by intestinal manipulation with or without preoperative vagotomy. CPSI-2364 was administered preoperatively via gavage in a dose- and time-dependent manner. ME specimens were assessed for p38-MAP kinase activity by immunoblotting, neutrophil extravasation, and nitric oxide production. Furthermore, in vivo gastrointestinal (GIT) and colonic transit were measured.
Results
Autoradiography demonstrated a near-exclusive detection of CPSI-2364 within the gastrointestinal wall and contents. Preoperative CPSI-2364 application significantly reduced postoperative neutrophil counts, nitric oxide release, GIT deceleration, and delay of colonic transit time, while intraoperatively administered CPSI-2364 failed to improve POI. CPSI-2364 also prevents postoperative neutrophil increase and GIT deceleration in vagotomized mice.
Conclusions
Orally administered CPSI-2364 shows a near-exclusive dispersal in the gastrointestinal tract and effectively reduces POI independently of central vagus nerve stimulation. Its efficacy after single oral dosage affirms CPSI-2364 treatment as a promising strategy for prophylaxis of POI.
Similar content being viewed by others
Abbreviations
- ME:
-
Muscularis externa
- KHB:
-
Krebs–Henseleit buffer
- GIT:
-
Gastrointestinal transit
- POI:
-
Postoperative ileus
- PMN:
-
Polymorphonuclear neutrophils
- p38-MAPK:
-
p38 Mitogen-activated protein kinase
- NO:
-
Nitric oxide
- IM:
-
Intestinal manipulation
- icv:
-
Intracerebroventricular
References
Bauer AJ, Schwarz NT, Moore BA, Turler A, Kalff JC (2002) Ileus in critical illness: mechanisms and management. Curr Opin Crit Care 8:152–157
Kehlet H (2000) Postoperative ileus. Gut 47(Suppl 4):iv85–iv86
Iyer S, Saunders WB, Stemkowski S (2009) Economic burden of postoperative ileus associated with colectomy in the United States. J Manag Care Pharm 15:485–494
Goldstein J, Matuszewski K, Delaney CP, Senagore A, Chiao E, Shah M, Meyer K, Bramley T (2007) Inpatient economic burden of postoperative ileus associated with abdominal surgery in the United States. P&T 32:82–90
Fukuda H, Tsuchida D, Koda K, Miyazaki M, Pappas TN, Takahashi T (2007) Inhibition of sympathetic pathways restores postoperative ileus in the upper and lower gastrointestinal tract. J Gastroenterol Hepatol 22:1293–1299
Bauer AJ, Boeckxstaens GE (2004) Mechanisms of postoperative ileus. Neurogastroenterol Motil 16(Suppl 2):54–60
Boeckxstaens GE, de Jonge WJ (2009) Neuroimmune mechanisms in postoperative ileus. Gut 58:1300–1311
Kalff JC, Carlos TM, Schraut WH, Billiar TR, Simmons RL, Bauer AJ (1999) Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 117:378–387
Kalff JC, Schraut WH, Simmons RL, Bauer AJ (1998) Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg 228:652–663
Kalff JC, Turler A, Schwarz NT, Schraut WH, Lee KK, Tweardy DJ, Billiar TR, Simmons RL, Bauer AJ (2003) Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann Surg 237:301–315
Wehner S, Schwarz NT, Hundsdoerfer R, Hierholzer C, Tweardy DJ, Billiar TR, Bauer AJ, Kalff JC (2005) Induction of IL-6 within the rodent intestinal muscularis after intestinal surgical stress. Surgery 137:436–446
Kalff JC, Buchholz BM, Eskandari MK, Hierholzer C, Schraut WH, Simmons RL, Bauer AJ (1999) Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 126:498–509
Kalff JC, Schraut WH, Billiar TR, Simmons RL, Bauer AJ (2000) Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 118:316–327
Schwarz NT, Kalff JC, Turler A, Engel BM, Watkins SC, Billiar TR, Bauer AJ (2001) Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 121:1354–1371
Wehner S, Behrendt FF, Lyutenski BN, Lysson M, Bauer AJ, Hirner A, Kalff JC (2007) Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents. Gut 56:176–185
Kalff JC, Schwarz NT, Walgenbach KJ, Schraut WH, Bauer AJ (1998) Leukocytes of the intestinal muscularis: their phenotype and isolation. J Leukoc Biol 63:683–691
de Jonge WJ, The FO, van der Coelen D, Bennink RJ, Reitsma PH, van Deventer SJ, van den Wijngaard RM, Boeckxstaens GE (2004) Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice. Gastroenterology 127:535–545
Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ (1998) Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci U S A 95:14429–14434
Wehner S, Straesser S, Vilz TO, Pantelis D, Sielecki T, de la Cruz V, Hirner A, Kalff JC (2009) Inhibition of p38 mitogen-activated protein kinase pathway as prophylaxis of postoperative ileus in mice. Gastroenterology 136:619–629
Lowenberg M, Verhaar A, van den Blink B, ten Kate F, van Deventer S, Peppelenbosch M, Hommes D (2005) Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease. J Immunol 175:2293–2300
Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM, Tracey KJ (2002) Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 195:781–788
The FO, Cailotto C, van der Vliet J, de Jonge WJ, Bennink RJ, Buijs RM, Boeckxstaens GE (2011) Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus. Br J Pharmacol 163(5):1007–1016
Institute of Laboratory Animal Resources (1996) Guide for the care and use of laboratory animals. National Academy, Washington, DC
Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209
Turler A, Moore BA, Pezzone MA, Overhaus M, Kalff JC, Bauer AJ (2002) Colonic postoperative inflammatory ileus in the rat. Ann Surg 236:56–66
The FO, de Jonge WJ, Bennink RJ, van den Wijngaard RM, Boeckxstaens GE (2005) The ICAM-1 antisense oligonucleotide ISIS-3082 prevents the development of postoperative ileus in mice. Br J Pharmacol 146:252–258
Schmidt J, Stoffels B, Nazir A, haven-Hudkins DL, Bauer AJ (2008) Alvimopan and COX-2 inhibition reverse opioid and inflammatory components of postoperative ileus. Neurogastroenterol Motil 20:689–699
Wattchow DA, De FD, Bampton PA, Leach PL, McLaughlin K, Costa M (2009) Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo. Aliment Pharmacol Ther 30:987–998
de Jonge WJ, The FO, Lowenberg M, Boeckxstaens GE (2009) P38 MAPK inhibitor semapimod reduces postoperative ileus via peripheral and central mechanisms. Gastroenterology 136:1841–1842
Bianchi M, Ulrich P, Bloom O, Meistrell M III, Zimmerman GA, Schmidtmayerova H, Bukrinsky M, Donnelley T, Bucala R et al (1995) An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med 1:254–266
Borovikova LV, Ivanova S, Nardi D, Zhang M, Yang H, Ombrellino M, Tracey KJ (2000) Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 85:141–147
Acknowledgments
We greatly appreciate Cytokine PharmaSciences, Inc. (King of Prussia, PA, USA) for providing CPSI-2364. This study was supported by grants from the Deutsche Forschungsgemeinschaft (KA1270/3-1/2) and BONFOR (O-112.0040 and O-112.0043).
Conflicts of interest
Thais Sielecki was an employee of Cytokine PharmaSciences, Inc., King of Prussia, PA, USA and an inventor on several patents and applications relating to CPSI-2364 that are owned by Cytokine PharmaSciences, Inc. Sven Wehner and Joerg Kalff are inventors on an international PCT application related to CPSI-2364 that is owned by Cytokine PharmaSciences, Inc. and the University of Bonn, Germany. All other authors have nothing to declare. The authors state that they have full control of all primary data and that they agree to allow the journal to review the data if requested.
Author information
Authors and Affiliations
Corresponding author
Additional information
S. Wehner and T. O. Vilz contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wehner, S., Vilz, T.O., Sommer, N. et al. The novel orally active guanylhydrazone CPSI-2364 prevents postoperative ileus in mice independently of anti-inflammatory vagus nerve signaling. Langenbecks Arch Surg 397, 1139–1147 (2012). https://doi.org/10.1007/s00423-012-0989-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-012-0989-6